Psorinoheel

Manufacturer: Heel Inc
Effective date: 2013-12-19
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:05:32

Label at a glance#

ProductPsorinoheel

Active ingredientSULFUR, THUJA OCCIDENTALIS LEAFY TWIG, VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN, BUFO BUFO CUTANEOUS GLAND, SCABIES LESION LYSATE (HUMAN), GONORRHEAL URETHRAL SECRETION HUMAN, NERIUM OLEANDER LEAF, CICUTA VIROSA ROOT, POTASSIUM DICHROMATE

Label structure10 sections

Dosage and administration

Dosage: Adults and children above 6 years: 1 vial orally 1-3 times daily Children up to 6 years: ½ vial orally 1-3 times daily

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Each1.1 ml ampule contains:

Ingredient Name	Potency	Quantity
Bacillinum	12x	0.55µ
Bufo rana	10x	1.1µ
Cictuta virosa	5x	0.55µ
Kali bismuthum iodatum	5x	0.55 µ
Medorrhinum	12x	1.1µ
Natrum muriaticum	12x	1.1µ
Oleander	4x	0.55µ
Psorinum	10x	1.1µ
Sulphur	6x	1.1µ
Thuja occidentalis	6x	1.1µ
Vaccinotoxinum	8x	1.1µ

Inactive Ingredient: Isotonic Sodium Chloride solution

INDICATION AND USAGE

INDICATIONS & USAGE SECTION

Psorinoheel® Oral Vials is a homeopathic drug product indicated for the stimulation of the defense mechanism in chronic skin disorders, hepatic damage , and chronic illness

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Dosage:

Adults and children above 6 years: 1 vial orally 1-3 times daily

Children up to 6 years: ½ vial orally 1-3 times daily

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Contraindications

Psorinoheel^® Oral Vials are contraindicated in patients with known hypersensitivity to Psorinoheel^® or any of its ingredients.

WARNINGS AND PRECAUTIONS

WARNINGS AND PRECAUTIONS SECTION

Warnings and Precautions

None

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

No adverse events have been reported with a causal relationship Psorinoheel^® Oral Vials.

OVERDOSAGE

OVERDOSAGE SECTION

Overdosage: No negative effects of an overdose have been reported and none are expected due to the homeopathic dilutions

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Mechanism of Action

The exact mechanism of Psorinoheel^® Oral Vials is not fully understood.

Pharmacodynamics

Not applicable for homeopathic medicinal products.

DOSAGE

DOSAGE FORMS & STRENGTHS SECTION

1 oral vial containing 1.1 ml solution for oral administration

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Psorinoheel oral vial.jpg

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50114-5324-6	2019-11-27	C162847	48780-1	9855e2a2-3fd8-60a7-e053-dbdaa90a05bd	Psorinoheel oral vial

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50114-5324-6	Psorinoheel	10 in 1 CARTON	SOLUTION	10		1
50114-5324-6	Psorinoheel	1.1 mL in 1 AMPULE	SOLUTION	1.1		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50114-5324	PSORINOHEEL (SULFUR, THUJA OCCIDENTALIS LEAFY TWIG, VACCINIA VIRUS STRAIN NEW YORK CITY BOARD, GONORRHEAL URETHRAL SECRETION HUMAN,SODIUM CHLORIDE, NERIUM OLEANDER LEAF,CICUTA VIROSA ROOT,) SOLUTION [HEEL INC]	1	Legacy NDC, 2 package rows	20140325_5c31cacd-c3e1-4241-beca-29f1b28a6fd1.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
BUFO BUFO CUTANEOUS GLAND	ACTIVE INGREDIENT	Q59QU6N72Q	1
CICUTA VIROSA ROOT	ACTIVE INGREDIENT	YEA9P21S8N	1
GONORRHEAL URETHRAL SECRETION HUMAN	ACTIVE INGREDIENT	9BZG9E3I8F	1
NERIUM OLEANDER LEAF	ACTIVE INGREDIENT	7KV510R6H6	1
POTASSIUM DICHROMATE	ACTIVE INGREDIENT	T4423S18FM	1
SCABIES LESION LYSATE (HUMAN)	ACTIVE INGREDIENT	5UAU16Z1U4	1
SULFUR	ACTIVE INGREDIENT	70FD1KFU70	1
THUJA OCCIDENTALIS LEAFY TWIG	ACTIVE INGREDIENT	1NT28V9397	1
VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN	ACTIVE INGREDIENT	4SV59689SK	1
BUFO BUFO CUTANEOUS GLAND	ACTIVE MOIETY	Q59QU6N72Q	1
CICUTA VIROSA ROOT	ACTIVE MOIETY	YEA9P21S8N	1
DICHROMATE ION	ACTIVE MOIETY	9LKY4BFN2V	1
GONORRHEAL URETHRAL SECRETION HUMAN	ACTIVE MOIETY	9BZG9E3I8F	1
NERIUM OLEANDER LEAF	ACTIVE MOIETY	7KV510R6H6	1
SCABIES LESION LYSATE (HUMAN)	ACTIVE MOIETY	5UAU16Z1U4	1
SULFUR	ACTIVE MOIETY	70FD1KFU70	1
THUJA OCCIDENTALIS LEAFY TWIG	ACTIVE MOIETY	1NT28V9397	1
VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN	ACTIVE MOIETY	4SV59689SK	1
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

Psorinoheel
SULFUR, THUJA OCCIDENTALIS LEAFY TWIG, VACCINIA VIRUS STRAIN NEW YORK CITY BOARD, GONORRHEAL URETHRAL SECRETION HUMAN,SODIUM CHLORIDE, NERIUM OLEANDER LEAF,CICUTA VIROSA ROOT,
SULFUR
THUJA OCCIDENTALIS LEAFY TWIG
VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN
BUFO BUFO CUTANEOUS GLAND
SCABIES LESION LYSATE (HUMAN)
GONORRHEAL URETHRAL SECRETION HUMAN
NERIUM OLEANDER LEAF
CICUTA VIROSA ROOT
POTASSIUM DICHROMATE
DICHROMATE ION
SODIUM CHLORIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
50114-5324	50114-5324-6

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SULFUR	70FD1KFU70	ACTIB
THUJA OCCIDENTALIS LEAFY TWIG	1NT28V9397	ACTIB
VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN	4SV59689SK	ACTIB
BUFO BUFO CUTANEOUS GLAND	Q59QU6N72Q	ACTIB
SCABIES LESION LYSATE (HUMAN)	5UAU16Z1U4	ACTIB
GONORRHEAL URETHRAL SECRETION HUMAN	9BZG9E3I8F	ACTIB
NERIUM OLEANDER LEAF	7KV510R6H6	ACTIB
CICUTA VIROSA ROOT	YEA9P21S8N	ACTIB
POTASSIUM DICHROMATE	T4423S18FM	ACTIB
SODIUM CHLORIDE	451W47IQ8X	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 134 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / INTRASYNOVIAL		4 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	POWDER / TOPICAL	NA		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL	226 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SPRAY, METERED / NASAL		36 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	POWDER, FOR SUSPENSION / ENDOTRACHEAL	46.76 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIAL	1.35 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION/ DROPS / OPHTHALMIC		55 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / TOPICAL	0.32 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS	0.86 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / EPIDURAL		648 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL	226 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION / PARENTERAL		210 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	LOTION / TOPICAL	0.3 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / ORAL		148 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / INTRAOCULAR		320 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRAVENOUS		28773 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	CAPSULE, EXTENDED RELEASE / ORAL		41 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / ENDOTRACHEAL	7.6 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	TABLET, ORALLY DISINTEGRATING / ORAL		10 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / INTRAVITREAL		6 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRATUMOR	1.2 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / INTRAMUSCULAR		26 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	TABLET, DELAYED RELEASE / ORAL		97 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	TABLET, EXTENDED RELEASE / ORAL	335.1 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	GEL / OPHTHALMIC	0.9 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / INTRAPERITONEAL	0.54 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION / INTRAVENOUS		2916 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / RESPIRATORY (INHALATION)		108 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	LIQUID / SUBCUTANEOUS	0.7 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR	0.86 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SPRAY / NASAL		30 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION, CONCENTRATE / INTRAMUSCULAR	0.86 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / EPIDURAL	0.9 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	TABLET / ORAL		231 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / OPHTHALMIC		13 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	LIQUID / INTRAMUSCULAR		17 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / PARENTERAL		584 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	TABLET, FILM COATED / ORAL		100 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	TABLET, CHEWABLE / ORAL		20 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	0.68 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, EMULSION / INTRAVENOUS	0.62 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	GEL / VAGINAL	10 %w/w		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRAMUSCULAR		1486 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SUSPENSION / INTRA-ARTICULAR		45 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / INTRAMUSCULAR	9 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	GEL / TOPICAL	0.18 %w/w		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOAP / TOPICAL	1.26 %w/w		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	DROPS / NASAL	NA		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / SOFT TISSUE		26 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	JELLY / NASAL	NA		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRADERMAL	7 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / INTRAVENOUS		90 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	TABLET, COATED / ORAL	54.7 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / OPHTHALMIC		10 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	POWDER / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRALESIONAL	0.9 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION / EPIDURAL		3535 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / SUBCUTANEOUS	0.8 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / INTRA-ARTICULAR		26 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / RECTAL	NA		Exact identifier — unii candidate 134 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
6bd1d376-97d2-4876-96e6-31c7ad4903cb			5c31cacd-c3e1-4241-beca-29f1b28a6fd1	2013-12-19	Warnings, Adverse reactions	Exact identifier spl id: 6bd1d376-97d2-4876-96e6-31c7ad4903cb spl set id: 5c31cacd-c3e1-4241-beca-29f1b28a6fd1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.